| 29th Apr 2014 1:48 pm |
RNS |
Form 8.5 (EPT/RI) |
| 29th Apr 2014 1:42 pm |
BUS |
Form 8.3 - Pfizer Inc |
| 29th Apr 2014 11:55 am |
RNS |
Form 8.3 - Pfizer, Inc. |
| 29th Apr 2014 11:54 am |
RNS |
Form 8.5 (EPT/RI) Pfizer Inc |
| 29th Apr 2014 11:52 am |
RNS |
Form 8.5 (EPT/RI)Pfizer Inc |
| 29th Apr 2014 11:51 am |
RNS |
Form 8.5 (EPT/RI) Pfizer Inc |
| 29th Apr 2014 10:55 am |
BUS |
Form 8.3 - Pfizer Inc |
| 29th Apr 2014 10:49 am |
BUS |
Form 8.3 - Pfizer Inc |
| 29th Apr 2014 8:24 am |
RNS |
Rule 2.10 Announcement |
| 29th Apr 2014 7:00 am |
RNS |
Form 8.5 (EPT/NON-RI) |
| 29th Apr 2014 7:00 am |
RNS |
Form 8.5 (EPT/NON-RI) |
| 28th Apr 2014 5:32 pm |
RNS |
Form 8.3 - Pfizer Inc |
| 28th Apr 2014 5:31 pm |
RNS |
Form 8.3 - Replacement AstraZenica Plc |
| 28th Apr 2014 4:51 pm |
RNS |
Form 8.3 - Pfizer/AstraZeneca PLC |
| 28th Apr 2014 3:36 pm |
RNS |
Form 8.3 - AstraZeneca Plc |
| 28th Apr 2014 10:43 am |
BUS |
Form 8 (OPD) - Pfizer Inc |
| 28th Apr 2014 7:00 am |
RNS |
Statement re Possible Offer |
| 28th Aug 2013 7:00 am |
RNS |
US$1 million Milestone Payment from Pfizer |
| 14th Aug 2012 7:00 am |
RNS |
Partners Pfizer for over-the-counter Nexium |
| 4th May 2011 7:00 am |
RNS |
Pfizer License Extension |
| 1st Feb 2011 1:01 pm |
BUS |
Pfizer Announces New $5 Billion Share Repurchase Program |
| 1st Feb 2011 1:00 pm |
BUS |
Pfizer Reports Fourth-Quarter and Full-Year 2010 Results; Provides 2011 Financial Guidance and Updates 2012 Financial Targets |
| 21st Jan 2011 1:15 pm |
BUS |
Pfizer Extends Tender Offer to Acquire King Pharmaceuticals, Inc. to January 28, 2011 |
| 12th Jan 2011 1:00 pm |
BUS |
Pfizer Initiates Rolling Submission For A New Drug Application In The U.S. For Its Fast-Tracked Investigational Compound Crizotinib (PF-02341066) For Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer |
| 17th Jun 2010 12:46 pm |
PRN |
Research Update |
| 18th May 2010 1:45 pm |
PRN |
Pfizer Plans to Reconfigure Global Plant Network |
| 12th May 2010 2:32 pm |
PRN |
Re Contract |
| 4th May 2010 12:46 pm |
PRN |
1st Quarter Results |
| 23rd Apr 2010 5:00 pm |
BUS |
World Bank And Pfizer Announce Initiative To Help Improve Healthcare Delivery In Developing Countries |
| 23rd Apr 2010 7:00 am |
BUS |
Pfizer Discontinues Phase 3 Trial of Sutent® in Advanced Hepatocellular Carcinoma |
| 14th Apr 2010 1:00 pm |
BUS |
Pfizer Oncology To Present Over 30 Abstracts On Pre-Clinical And Clinical Research At The American Association For Cancer Research Annual Meeting |
| 6th Apr 2010 7:00 am |
BUS |
Pfizer And Acacia Living Partner To Support Seniors In Living Independently |
| 1st Apr 2010 7:00 am |
BUS |
Pfizer Posts Details About Interactions With U.S. Physicians, Other Healthcare Professionals And Clinical Research Partners |
| 17th Mar 2010 12:00 pm |
BUS |
Study Shows Prevenar 13* Is Immunogenic In Young Children Previously Vaccinated With Prevenar* |
| 16th Mar 2010 7:00 am |
BUS |
Intensive Lipitor Therapy Was Associated With Reduced Risk Of Cardiovascular Events In Two High-Risk Patient Groups |
| 12th Mar 2010 7:00 am |
BUS |
Two Phase 3 Trials Of Sunitinib With Commonly Used Chemotherapies In Advanced Breast Cancer Did Not Meet The Primary Endpoint |
| 12th Mar 2010 7:00 am |
BUS |
Pfizer Discontinues A Phase 3 Study Of Figitumumab In Previously Treated Patients With Advanced Non-Small Cell Lung Cancer |
| 5th Mar 2010 7:00 am |
BUS |
ADVANCE-2 Study Results Demonstrate Investigational Anticoagulant Apixaban Was Statistically Superior To Enoxaparin In The Prevention Of Venous Thromboembolism Following Knee Replacement Surgery |
| 3rd Mar 2010 12:30 pm |
BUS |
Pfizer And Medivation Announce Results From Two Phase 3 Studies In Dimebon (latrepirdine*) Alzheimer's Disease Clinical Development Program |
| 25th Feb 2010 7:00 am |
BUS |
CDC's Advisory Committee On Immunization Practices Recommends Pfizer's Prevnar 13™ Vaccine For The Prevention Of Invasive Pneumococcal Disease In Infants And Young Children In The U.S. |
